Immunohistochemistry

Immunohistochemistry (IHC) is a specialised laboratory technique that uses antibodies to detect specific proteins within tissue samples, helping pathologists precisely classify tumours and other diseases beyond what standard microscopy alone can reveal. It is especially important in cancer diagnosis, where identifying specific protein markers can determine the exact tumour type, its origin, and whether it is likely to respond to targeted therapies such as hormone or immunotherapy treatments. The technique works by applying antibodies that bind to particular proteins in the tissue, which are then visualised with a colour-producing stain under the microscope. IHC has become an essential complement to routine histopathology in modern cancer diagnosis.

Immunohistochemistry is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Pathology & Laboratory Medicine specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is 2-5 days turnaround. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes There is no recovery involved as this is purely a laboratory analysis. Results typically take 2-5 days depending on the number of markers tested and are incorporated into the final pathology report used to guide treatment.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Immunohistochemistry has a documented success rate of Highly effective at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.